Sphingolipids	NNS
in	IN
pulmonary	JJ
fibrosis	NN
.	.

Idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
is	VBZ
a	DT
devastating	JJ
disease	NN
characterized	VBN
by	IN
alveolar	JJ
epithelial	JJ
cell	NN
injury	NN
,	,
accumulation	NN
of	IN
fibroblasts/myofibroblasts	NNS
and	CC
deposition	NN
of	IN
extracellular	JJ
matrix	NN
proteins	NNS
.	.

Levels	NNS
of	IN
sphingosine-1-phosphate	NN
(	(
S1P	NN
)	)
,	,
a	DT
naturally	RB
occurring	VBG
bioactive	JJ
lipid	NN
,	,
are	VBP
elevated	JJ
in	IN
bronchoalveolar	JJ
fluids	NNS
and	CC
lung	NN
tissues	NNS
from	IN
IPF	NN
patients	NNS
and	CC
animal	NN
models	NNS
of	IN
pulmonary	JJ
fibrosis	NN
.	.

However	RB
,	,
the	DT
in	FW
vivo	FW
contribution	NN
of	IN
S1P	NN
,	,
regulated	VBN
by	IN
its	PRP$
synthesis	NN
catalyzed	VBN
by	IN
Sphingosine	NN
kinases	NNS
(	(
SphKs	NNS
)	)
1	CD
		NN
2	CD
and	CC
catabolism	NN
by	IN
S1P	NN
phosphatases	NNS
and	CC
S1P	NN
lyase	NN
(	(
S1PL	NN
)	)
,	,
in	IN
the	DT
pathogenesis	NN
of	IN
pulmonary	JJ
fibrosis	NN
is	VBZ
not	RB
well	RB
defined	VBN
.	.

Microarray	NN
analysis	NN
of	IN
blood	NN
mononuclear	JJ
cells	NNS
from	IN
patients	NNS
with	IN
IPF	NN
and	CC
SphK1	NN
-	:
,	,
SphK2	NN
-	:
or	CC
S1PL-knockout	JJ
mice	NNS
and	CC
SphK	NN
inhibitor	NN
were	VBD
used	VBN
to	TO
assess	VB
the	DT
role	NN
of	IN
S1P	NN
in	IN
fibrogenesis	NN
.	.

The	DT
expression	NN
of	IN
SphK1	NN
negatively	RB
correlated	VBD
with	IN
lung	NN
function	NN
and	CC
survival	NN
of	IN
patients	NNS
with	IN
IPF	NN
.	.

Further	RB
,	,
the	DT
expressions	NNS
of	IN
SphK1	NN
and	CC
S1PL	NN
were	VBD
increased	VBN
in	IN
lung	NN
tissues	NNS
from	IN
patients	NNS
with	IN
IPF	NN
and	CC
bleomycin-challenged	JJ
mice	NNS
.	.

Genetic	JJ
knockdown	NN
of	IN
SphK1	NN
,	,
but	CC
not	RB
SphK2	NN
,	,
ameliorated	VBN
bleomycin-induced	JJ
pulmonary	JJ
fibrosis	NN
in	IN
mice	NNS
while	IN
deletion	NN
of	IN
S1PL	NN
(	(
SGPL1	NN
(	(
+	CC
/	:
-	:
)	)
)	)
in	IN
mice	NNS
potentiated	VBD
fibrosis	NN
post-bleomycin	JJ
challenge	NN
.	.

TGF-b	NN
increased	VBD
the	DT
expression	NN
of	IN
SphK1	NN
and	CC
S1PL	NN
in	IN
human	JJ
lung	NN
fibroblasts	NNS
and	CC
knockdown	NN
of	IN
SphK1	NN
or	CC
treatment	NN
with	IN
SphK	NN
inhibitor	NN
attenuated	VBD
S1P	NN
generation	NN
and	CC
TGF-b	NN
mediated	JJ
signal	NN
transduction	NN
.	.

Over-expression	NN
of	IN
S1PL	NN
attenuated	VBD
bleomycin-induced	JJ
TGF-b	NN
secretion	NN
and	CC
S1P	NN
mediated	VBD
differentiation	NN
of	IN
human	JJ
lung	NN
fibroblasts	NNS
through	IN
regulation	NN
of	IN
autophagy	NN
.	.

Administration	NN
of	IN
SphK1	NN
inhibitor	NN
8	CD
days	NNS
post-bleomycin	JJ
challenge	NN
reduced	VBD
bleomycin-induced	JJ
mortality	NN
and	CC
pulmonary	JJ
fibrosis	NN
.	.

Our	PRP$
results	NNS
suggest	VBP
that	IN
SphK1	NN
and	CC
S1PL	NN
play	VBP
critical	JJ
roles	NNS
in	IN
the	DT
pathology	NN
of	IN
lung	NN
fibrosis	NN
and	CC
may	MD
be	VB
novel	JJ
therapeutic	JJ
targets	NNS
.	.

